JP2002500886A5 - - Google Patents

Download PDF

Info

Publication number
JP2002500886A5
JP2002500886A5 JP2000528679A JP2000528679A JP2002500886A5 JP 2002500886 A5 JP2002500886 A5 JP 2002500886A5 JP 2000528679 A JP2000528679 A JP 2000528679A JP 2000528679 A JP2000528679 A JP 2000528679A JP 2002500886 A5 JP2002500886 A5 JP 2002500886A5
Authority
JP
Japan
Prior art keywords
polypeptide
seq
dna
1rrp1
acpl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000528679A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002500886A (ja
JP4271850B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/001419 external-priority patent/WO1999037772A1/en
Publication of JP2002500886A publication Critical patent/JP2002500886A/ja
Publication of JP2002500886A5 publication Critical patent/JP2002500886A5/ja
Application granted granted Critical
Publication of JP4271850B2 publication Critical patent/JP4271850B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000528679A 1998-01-23 1999-01-22 Il−18受容体 Expired - Fee Related JP4271850B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US7230198P 1998-01-23 1998-01-23
US7883598P 1998-03-20 1998-03-20
US60/072,301 1998-03-20
US60/078,835 1998-03-20
US9446998P 1998-07-28 1998-07-28
US60/094,469 1998-07-28
PCT/US1999/001419 WO1999037772A1 (en) 1998-01-23 1999-01-22 Il-18 receptors

Publications (3)

Publication Number Publication Date
JP2002500886A JP2002500886A (ja) 2002-01-15
JP2002500886A5 true JP2002500886A5 (https=) 2006-02-02
JP4271850B2 JP4271850B2 (ja) 2009-06-03

Family

ID=27372056

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000528679A Expired - Fee Related JP4271850B2 (ja) 1998-01-23 1999-01-22 Il−18受容体

Country Status (13)

Country Link
US (4) US6589764B1 (https=)
EP (1) EP1047781B1 (https=)
JP (1) JP4271850B2 (https=)
AT (1) ATE272114T1 (https=)
AU (1) AU737592B2 (https=)
CA (1) CA2318482C (https=)
DE (1) DE69918946T2 (https=)
DK (1) DK1047781T3 (https=)
ES (1) ES2226335T3 (https=)
IL (2) IL137178A0 (https=)
NZ (1) NZ505880A (https=)
PT (1) PT1047781E (https=)
WO (1) WO1999037772A1 (https=)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326472B1 (en) 1997-10-15 2001-12-04 Schering Corporation Human receptor proteins; related reagents and methods
US6472179B2 (en) * 1998-09-25 2002-10-29 Regeneron Pharmaceuticals, Inc. Receptor based antagonists and methods of making and using
US7083949B2 (en) 1998-09-25 2006-08-01 Regeneron Pharmaceuticals, Inc. Receptor based antagonists and methods of making and using
US6927044B2 (en) 1998-09-25 2005-08-09 Regeneron Pharmaceuticals, Inc. IL-1 receptor based cytokine traps
US20020155526A1 (en) 1998-09-30 2002-10-24 Busfield Samantha J. Novel secreted immunomodulatory proteins and uses thereof
US6610286B2 (en) 1999-12-23 2003-08-26 Zymogenetics, Inc. Method for treating inflammation using soluble receptors to interleukin-20
JP4741139B2 (ja) * 1999-12-23 2011-08-03 ザイモジェネティクス, インコーポレイテッド 可溶性インターロイキン−20レセプター
US7122632B2 (en) 1999-12-23 2006-10-17 Zymogenetics, Inc. Soluble Interleukin-20 receptor
TWI335336B (https=) 2000-02-10 2011-01-01 Abbott Gmbh & Co Kg
US20020025317A1 (en) * 2000-07-20 2002-02-28 Schering Ag Bispecific monoclonal antibodies to IL-12 and IL-18
US20020052475A1 (en) * 2000-07-20 2002-05-02 Schering Ag High affinity soluble interleukin-18 receptor
ES2381650T3 (es) 2000-08-08 2012-05-30 Zymogenetics, Inc. Receptores de citoquinas Zcytor11 solubles
JP4908723B2 (ja) 2000-09-15 2012-04-04 ザイモジェネティクス, インコーポレイテッド 炎症を治療するための方法
CA2424983A1 (en) 2000-10-11 2002-04-18 Viron Therapeutics, Inc. Nucleic acid molecules and polypeptides for immune modulation
US7718368B2 (en) * 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
GB2375604A (en) * 2001-05-18 2002-11-20 Warner Lambert Co Methods for screening using interleukin soluble trimolecular complex
PH12012502440A1 (en) 2001-06-26 2013-06-17 Amgen Inc Antibodies to opgl
EP1293566A1 (en) * 2001-09-17 2003-03-19 Societe Des Produits Nestle S.A. A soluble toll-like receptor
CA2467723C (en) 2001-12-17 2011-09-27 Zymogenetics, Inc. Method for treating cervical cancer
AU2003259995B2 (en) 2002-08-28 2009-07-02 Immunex Corporation Compositions and methods for treating cardiovascular disease
MXPA05003869A (es) 2002-10-08 2005-06-22 Ares Trading Sa El uso de citocina capaz de enlazarse a la proteina de union a interleucina-18, y de inhibir la actividad de una segunda citocina.
EP1606316A2 (en) 2003-03-24 2005-12-21 ZymoGenetics, Inc. Anti-il-20 antibodies and binding partners and methods of using in inflammation
TWI353991B (en) 2003-05-06 2011-12-11 Syntonix Pharmaceuticals Inc Immunoglobulin chimeric monomer-dimer hybrids
US20050100965A1 (en) 2003-11-12 2005-05-12 Tariq Ghayur IL-18 binding proteins
US7968684B2 (en) * 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
DE602004023965D1 (de) 2003-11-21 2009-12-17 Zymogenetics Inc Anti-il-20-antikörper und bindungspartner und verfahren zur anwendung bei entzündungen
US7141382B1 (en) 2004-10-12 2006-11-28 Parikh Chirag R Methods for detection of IL-18 as an early marker for diagnosis of acute renal failure and predictor of mortality
JP4898691B2 (ja) 2004-10-22 2012-03-21 ザイモジェネティクス, インコーポレイテッド 抗il−22ra抗体および結合パートナー、ならびに炎症における使用法
AU2005327508A1 (en) * 2005-02-15 2006-08-24 Apollo Life Sciences Limited Molecules and chimeric molecules thereof
JP2009527535A (ja) * 2006-02-22 2009-07-30 ユニバーシティ オブ チューリッヒ 自己免疫疾患又は脱髄疾患を処置するための可溶性受容体及び方法
JP5368301B2 (ja) 2006-06-22 2013-12-18 ノボ・ノルデイスク・エー/エス 可溶性ヘテロ二量体レセプター及びその使用
MX2009012343A (es) * 2007-05-14 2010-02-10 Biogen Idec Inc Regiones fc (sc fc) de cadena sencilla, polipeptidos de enlace que comprenden las mismas, y metodos relacionados con ello.
CL2008002153A1 (es) 2007-07-24 2009-06-05 Amgen Inc Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r.
BR112012021576A2 (pt) 2010-02-26 2016-10-25 Novo Nordisk As composições estáveis contendo anticorpo.
RU2012153786A (ru) 2010-05-28 2014-07-10 Ново Нордиск А/С Стабильные многодозовые композиции, содержащие антитело и консервант
SG10201505217WA (en) 2010-07-09 2015-08-28 Biogen Hemophilia Inc Chimeric clotting factors
JP5813114B2 (ja) 2010-08-25 2015-11-17 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Il−18r1に対する抗体およびその使用
US9376489B2 (en) 2012-09-07 2016-06-28 Novartis Ag IL-18 binding molecules

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989004838A1 (en) 1987-11-25 1989-06-01 Immunex Corporation Interleukin-1 receptors
EP0533006A1 (en) * 1991-09-18 1993-03-24 F.Hoffmann-La Roche & Co. Aktiengesellschaft Chimaeric interleukin 5-receptor/immunoglobulin polypeptides
US5470952A (en) 1993-10-20 1995-11-28 Regeneron Pharmaceuticals, Inc. CNTF and IL-6 antagonists
WO1996013593A2 (en) * 1994-10-26 1996-05-09 Procept, Inc. Soluble single chain t cell receptors
US5853721A (en) 1995-01-31 1998-12-29 Hoffmann-La Roche Inc. Antibody to interleukin-12 receptor
US5840530A (en) * 1995-08-01 1998-11-24 Hoffmann-La Roche Inc. DNA encoding receptors for the beta-2 chain of human IL-12
US5776731A (en) 1996-02-21 1998-07-07 Immunex Corporation DNA encoding type-I interleukin-I receptor-like protein designated 2F1
US7141393B2 (en) 1996-12-26 2006-11-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18-receptor proteins
US6087116A (en) 1997-03-12 2000-07-11 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18 (IL-18) receptor polypeptides and their uses
US6326472B1 (en) 1997-10-15 2001-12-04 Schering Corporation Human receptor proteins; related reagents and methods
US6280955B1 (en) * 1997-12-16 2001-08-28 Tularik Inc. Interleukin-1 receptor accessory proteins, nucleic acids and methods
US6472179B2 (en) 1998-09-25 2002-10-29 Regeneron Pharmaceuticals, Inc. Receptor based antagonists and methods of making and using
US20020052475A1 (en) 2000-07-20 2002-05-02 Schering Ag High affinity soluble interleukin-18 receptor

Similar Documents

Publication Publication Date Title
JP2002500886A5 (https=)
CA2318482A1 (en) Il-18 receptors
JP2002508183A5 (https=)
KR960704038A (ko) 세포 표면 수용체 Hek와 결합하는 사이토킨(Cytokines That Bind the Cell Surface Receptor Hek)
JP2003512011A5 (https=)
JP2019506166A5 (https=)
JP2002536960A5 (https=)
JP2002514418A5 (https=)
CA2190371A1 (en) Receptor for oncostatin m
JP2004528014A5 (https=)
DK2190863T3 (en) New albumin binding compositions, methods and uses
JP2006516189A5 (https=)
WO2003070760A3 (en) Anti-amyloid beta antibodies and their use
JP2002532561A5 (https=)
JP2007500744A5 (https=)
CA2225378A1 (en) Cytokine that induces apoptosis
CA2289912A1 (en) Human receptor proteins; related reagents and methods
JP2012520059A5 (https=)
JP2003534013A5 (https=)
JP2006512894A5 (https=)
CA2179909A1 (en) Ligand that binds fas antigen
WO2000026244A3 (en) A novel tumor necrosis factor family member, drl, and related compositions and methods
RU2000103824A (ru) Адипоцит-специфические белковые гомологи
JP2002517193A5 (https=)
WO2000023565B1 (en) Novel neuropilin/growth factor binding and uses thereof